Hainan Poly Pharm Co. Ltd. is a leading pharmaceutical company in China，dedicated to providing therapeutic-value products and services to patients and customers around the world, which mainly involves in the activities of R&D, manufacturing and marketing.
Founded in 1992, Poly has built up an excellent product portfolio with producing both Active Pharmaceutical Ingredient (API) and finished products, and gained great reputation for its high-quality products. Poly initiated its international registration program in 2005. Since 2012, Poly has received inspections from authorities including US FDA, EU EMA, NMPA and WHO with positive outcoming, which has provided sound evidence of Poly's GMP compliance in practice and its efforts in quality control.
With the approval of products for marketing by EU EMA and US FDA, and distribution of its products to EU markets, Poly has already marched into the global market. In 2017, Poly Pharm successfully completed Initial Public Offering (IPO) and listed in Shenzhen Stock Exchange ( 300630.SZ)
Exporting countries and regions
Production permits for preparations to overseas markets
Innovation and invention patent
POLY Pharm Group
Hainan Poly Pharm (Manufacture)
Zhejiang Poly Pharm (Manufacture)
Anhui Poly Pharm (Manufacture)
Zhejiang Roly Pharm (Marketing&Sales)
Hainan Poly Pharm. Co., Ltd.
Guilingyang Economic Development Area, Haikou, Hainan 571127, P.R.China
Established in 1992,it is a high-tech enterprise specialized in R & D, registration, manufacturing and sales of APIs and finished products for domestic and overseas markets. . In June 2015, it was recognized by the Ministry of Industry and Information Technology as a pilot demonstration project for intelligent manufacturing (smart factory for pharmaceutical formulation production).
ZheJiang Poly Pharm. Co.,Ltd.
No.78 Xinzhou Road,Linping, Yuhang, Hangzhou, Zhejiang 311199, P.R.China
Established in 2013, it mainly produces tablets, capsules, granules, oral suspensions, ointments, injections, and eye drops, with an annual production line of 1.5 billion tablets/bags/capsules of finished products. The facility is equipped with a R&D center, and it was listed into the key projects for China Manufacturing 2025 Initiative for Pediatric Drugs by the Ministry of Industry. The oral solid workshop has been inspected by FDA and EMA and its injection workshop has been inspected by FDA for GMP compliance
AnHui Poly Pharm. Co., Ltd.
No. 58, Xiahong Road, High-tech Industrial Development Zone, Anqing City, Anhui Province
Anhui Poly Pharm is a professional supplier of active ingredients, dedicated to providing high-quality specialty ingredients (active ingredients and excipients) through chemical synthesis and biosynthesis and CMO/CDMO services for pharmaceuticals, nutritions and cosmetics worldwidely. Established in 2019, it has a strong and efficient R&D team, modern production lines meeting the US and EU standards. With a total investment of 1 billion RMB in the area of nearly 200 acres, it is the first international high-end API (active pharmaceutical ingredient) factory in Anqing City. The facility has received pre-approval inspection by FDA for pre-appovals.
Zhejiang Roly Pharm Co., LTD
No. 78, Xinzhou Road, Yuhang Economic Development Zone, Hangzhou, Zhejiang Province
Zhejiang Roly Pharm, a wholly-owned subsidiary of Zhejiang Poly Pharm, is specialized in the marketing and sales of pharmaceutical proudcts in domestic market. Its marketing network covers over 15,000 medical institutions in all provinces, municipalities, and autonomous regions throughout China, including over 5,000 secondary and above-level hospitals and specialized hospitals, and over 10,000 primary healthcare institutions. The company has established sustainable relationship with more than a thousand distributors and logistics partners.
Our Core Values
Good Medicine. Healthy People
Provide high-quality to the customers and patients all around the world
Honesty, Efficiency, Innovation, Professionalism
To become a leading supplier of the products for specific indications